Literature DB >> 22865374

On the efficiency of two-stage response-adaptive designs.

Holger Dette1, Björn Bornkamp, Frank Bretz.   

Abstract

In this paper, we investigate the efficiency of response-adaptive locally optimum designs. We focus on two-stage adaptive designs, where after the first stage the accrued data are used to determine a locally optimum design for the second stage. On the basis of an explicit expansion of the information matrix, we compare the variance of the maximum likelihood estimates obtained from a two-stage adaptive design and a fixed design without adaptation. For several one-parameter models, we provide explicit expressions for the relative efficiency of these two designs, which is seen to depend sensitively on the statistical problem under investigation. In particular, we show that in non-linear regression models with moderate or large variances the first-stage sample size of an adaptive design should be chosen sufficiently large in order to address variability in the interim parameter estimates. These findings support the results of recent simulation studies conducted to compare adaptive designs in more complex situations. We finally present an application to a real clinical dose-finding trial aiming at the estimation of the smallest dose achieving a certain percentage of the maximum treatment effect by using a three-parameter Emax model.
Copyright © 2012 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2012        PMID: 22865374     DOI: 10.1002/sim.5555

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Implementing Optimal Designs for Dose-Response Studies Through Adaptive Randomization for a Small Population Group.

Authors:  Yevgen Ryeznik; Oleksandr Sverdlov; Andrew C Hooker
Journal:  AAPS J       Date:  2018-07-19       Impact factor: 4.009

2.  Optimal designs for comparing curves.

Authors:  Holger Dette; Kirsten Schorning
Journal:  Ann Stat       Date:  2016-04-11       Impact factor: 4.028

3.  Adaptive Optimal Designs for Dose-Finding Studies with Time-to-Event Outcomes.

Authors:  Yevgen Ryeznik; Oleksandr Sverdlov; Andrew C Hooker
Journal:  AAPS J       Date:  2017-12-28       Impact factor: 4.009

4.  The effect of using a robust optimality criterion in model based adaptive optimization.

Authors:  Eric A Strömberg; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-04-06       Impact factor: 2.745

5.  Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial.

Authors:  Frank Waldron-Lynch; Paula Kareclas; Kathryn Irons; Neil M Walker; Adrian Mander; Linda S Wicker; John A Todd; Simon Bond
Journal:  BMJ Open       Date:  2014-06-04       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.